KFDA clarifies drug labeling and description issue

Published: 2006-11-24 06:57:00

Updated: 2006-11-24 06:57:00

In response to a recent civil petition on the labeling and description provisions of drugs, the Korea Food and Drug Administration said that in case of consigning some packaging process to other toll-manufacturing firm, the consignee will have no obligation to change the name and address of a man...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK